Imagion Biosystems Limited today announced “Appendix 3B New issue announcement, application for quotation of additional securities and agreement.”
Read Appendix 3B.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the